Tender detail
Ranibizumab drug rebate agreement
Summary
The tender concerns a rebate agreement for medicines containing ranibizumab for the period 01/09/2026 to 31/08/2028. It is an open procedure for the supply of medicines, and bidders should note that the exact qualification and compliance requirements must be checked in the tender documents.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.